The estimated Net Worth of Timothy P Sullivan is at least $2.56 milliard dollars as of 22 August 2024. Mr. Sullivan owns over 47,249 units of Option Care Health stock worth over $674,998 and over the last 9 years he sold OPCH stock worth over $2,555,210,467. In addition, he makes $220,000 as Director at Option Care Health.
Timothy has made over 13 trades of the Option Care Health stock since 2016, according to the Form 4 filled with the SEC. Most recently he sold 47,249 units of OPCH stock worth $1,460,467 on 22 August 2024.
The largest trade he's ever made was selling 20,700,000 units of Option Care Health stock on 5 August 2021 worth over $419,175,000. On average, Timothy trades about 5,122,802 units every 128 days since 2016. As of 22 August 2024 he still owns at least 20,814 units of Option Care Health stock.
You can see the complete history of Mr. Sullivan stock trades at the bottom of the page.
Timothy P. Sullivan serves as Director of the Company. He served on the legacy Option Care board from 2015 until the Merger. Mr. Sullivan is a founder and Managing Director of MDP, which specializes in management buyouts and special equity investing and manages over 18 billion dollars of committed capital and portfolio investments. Mr. Sullivan is also the Head of Madison Dearborn Partners’ Health Care team. Prior to co-founding MDP in 1993, Mr. Sullivan was with First Chicago Venture Capital for three years after having served in the U.S. Navy. Mr. Sullivan concentrates on investments in the health care sector and has served on the Boards of Alcami Corporation since 2018, Solis Mammography since 2018, Performance Health since 2015, and Kaufman, Hall & Associates, LLC since 2014. Mr. Sullivan also serves on the Board of Managers of our largest stockholder, HC Group. Mr. Sullivan previously served on the Board of Ikaria, Inc. from 2014 to 2015, VWR Corporation, which became a publicly-traded company in 2014, from 2007 to 2017, Sage Products LLC from 2012 to 2016, and Sirona Dental Systems Inc. from 2005 to 2016, completing a reverse merger with publicly-traded Schick Technologies in 2005. Mr. Sullivan holds a B.S. from the United States Naval Academy, an M.S. from the University of Southern California and an M.B.A. from the Stanford University Graduate School of Business. Mr. Sullivan’s extensive experience in financial transactions, investing in a range of businesses and the healthcare industry make him a valuable member of our Board.
As the Director of Option Care Health, the total compensation of Timothy Sullivan at Option Care Health is $220,000. There are 15 executives at Option Care Health getting paid more, with Harriet Booker having the highest compensation of $1,393,652.
Timothy Sullivan is 62, he's been the Director of Option Care Health since 2019. There are 3 older and 18 younger executives at Option Care Health. The oldest executive at Option Care Health, Inc. is John Arlotta, 70, who is the Independent Director.
Timothy's mailing address filed with the SEC is C/O MADISON DEARBORN PARTNERS, LLC, 70 WEST MADISON, SUITE 4600, CHICAGO, IL, 60602.
Over the last 5 years, insiders at Option Care Health have traded over $6,426,460,535 worth of Option Care Health stock and bought 202,320 units worth $5,246,552 . The most active insiders traders include Timothy P Sullivan, Elizabeth Quadros Betten et Dearborn Partners Llcmadiso.... On average, Option Care Health executives and independent directors trade stock every 28 days with the average trade being worth of $157,254,886. The most recent stock trade was executed by R Carter Pate on 3 September 2024, trading 1,465 units of OPCH stock currently worth $47,422.
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
Option Care Health executives and other stock owners filed with the SEC include: